An examination of the results of the EVIDENCE, INCOMIN, and phase III studies of interferon beta products in the treatment of multiple sclerosis
- 1 January 2003
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 25 (1) , 105-118
- https://doi.org/10.1016/s0149-2918(03)90013-0
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: